Skip to content
DataLookout
Menu

NCT06601101

Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus

StatusTerminated
PhasePhase 3
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 3 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial terminated Sponsor's reason: Enrollment closed before the planned 36 eyes were reached because of the limited number of eligible patients and the long recruitment period (July 2024 to December 2025); 20 eyes of 19 participants were enrolled. Show 9 more changesShow less
    • Eligibility criteria expanded, about 26 words
    • Final enrollment: 19 participants (planned 36)
    • Primary completion date changed from estimate of Oct 1, 2025 to Dec 25, 2025
    • Interventions modified
    • Study completion date changed from estimate of Oct 1, 2025 to Mar 20, 2026
    • Secondary endpoints: 2 to 4
    • Study description shortened, about 384 words
    • Site details revised
    • Collaborators expanded, about 10 words
  2. Notable Lead sponsor: Vitor Borges Guimaraes to University of Campinas, Brazilv2
  3. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed

Endpoints

Primary

Corneal Epithelial Healing Rate
Timeframe: From crosslinking until complete epithelialization, assessed at 18, 42 and 66 hours, on day 6 and every 48 hours thereafter.

Secondary (4)

Endothelial cell count
Incidence of corneal haze
Time to complete epithelialization
Adverse events

Arms and interventions

InsulinExperimental

NPH insulin 50 IU/mL eye drops (Eye Pharma, São Paulo, SP, Brazil), one drop four times daily until complete corneal epithelialization, added to the standard postoperative regimen.

PlaceboPlacebo comparator

0.5% methylcellulose eye drops (Eye Pharma, São Paulo, SP, Brazil), the vehicle of the insulin formulation, one drop four times daily until complete corneal epithelialization, added to the standard postoperative regimen.

Drugs: NPH insulin 50 IU/mL eye drops, 0.5% methylcellulose eye drops (placebo)

Sites

1 site in 1 country

  • State University of CampinasCampinas, São Paulo, Brazil